Literature DB >> 8605032

Specific processing of native and phosphorylated tau protein by proteases.

X Wang1, S An, J M Wu.   

Abstract

Protein tau is a group of developmentally regulated proteins with implications in the pathogenesis of Alzheimer's disease (AD). To study whether phosphorylation of tau by different protein kinases may affect subsequent reactivity to proteases, human recombinant tau-3 was phosphorylated with PKA or a double-stranded DNA-dependent protein kinase (referred to as DNA-PK), followed by incubation with thrombin or a double-stranded DNA (dsDNA)-stimulated protease. Quantitative degradation of tau was measured by the disappearance of the substrates or the appearance of products on SDS-PAGE. With thrombin, tau-3 phosphorylated by DNA-PK was degraded faster than the native protein which was processed at a faster rate than tau-3 phosphorylated by PKA. With the dsDNA-stimulated protease, however, tau-3 phosphorylated by PKA was processed faster than that phosphorylated by DNA-PK. Thrombin-mediated degradation of DNA-PK phosphorylated tau-3 gave a pattern different from that using the native or the PKA phosphorylated tau-3 as substrates. These results suggest that the rate and/or sequence of phosphorylation at specific sites of tau may provide "micro-environments" and/or conformations which alter their accessibility and/or reactivity to proteases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605032     DOI: 10.1006/bbrc.1996.0278

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  4 in total

1.  Prothrombin concentration in the cerebrospinal fluid is not altered in Alzheimer's disease.

Authors:  P Lewczuk; J Wiltfang; M Lange; H Jahn; H Reiber; H Ehrenreich
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

Review 2.  Roles of tau protein in health and disease.

Authors:  Tong Guo; Wendy Noble; Diane P Hanger
Journal:  Acta Neuropathol       Date:  2017-04-06       Impact factor: 17.088

Review 3.  Therapeutic strategies for the treatment of tauopathies: Hopes and challenges.

Authors:  Mansi R Khanna; Jane Kovalevich; Virginia M-Y Lee; John Q Trojanowski; Kurt R Brunden
Journal:  Alzheimers Dement       Date:  2016-10       Impact factor: 21.566

Review 4.  Tau clearance mechanisms and their possible role in the pathogenesis of Alzheimer disease.

Authors:  Adrianne S Chesser; Susanne M Pritchard; Gail V W Johnson
Journal:  Front Neurol       Date:  2013-09-03       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.